Is ESSA Pharma Inc. (EPIX) a Buy, Sell, or Hold?
NASDAQ : EPIX
ESSA Pharma Inc. — Institutional Ownership
$0.2012 USD
$0.0 (-1.85%)
- Volume
- 5.95M
- Average Volume
- 6.75M
- Market Capitalization
- $9.52M
- P/E Ratio
- -0.87
- Dividend Yield
- 0.00%
- Price Target
- $9.50
- Year High
- $6.45
- Year Low
- $0.18
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $69.07
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2025-11-14 | TANG CAPITAL MANAGEMENT, LLC | - | 0.00% |
| 2025-11-14 | TANG CAPITAL MANAGEMENT, LLC | - | 0.00% |
| 2025-10-14 | BIOTECHNOLOGY VALUE FUND L P | - | 0.00% |
| 2025-10-07 | Morgan Stanley | 1.9M | 4.00% |
| 2025-08-07 | BIOTECHNOLOGY VALUE FUND L P | 6.19M | 13.10% |
| 2025-07-30 | TANG CAPITAL MANAGEMENT, LLC | 4.3M | 9.70% |
| 2025-07-21 | SOLEUS CAPITAL GROUP, LLC | 4.36M | 9.80% |
| 2025-07-21 | SOLEUS CAPITAL MASTER FUND, L.P. | 4.36M | 9.80% |
| 2025-07-21 | SOLEUS CAPITAL, LLC | 4.36M | 9.80% |
| 2025-07-21 | GUY LEVY | 4.36M | 9.80% |
| 2025-07-21 | SOLEUS CAPITAL MANAGEMENT, L.P. | 4.36M | 9.80% |
| 2025-07-21 | SOLEUS GP, LLC | 4.36M | 9.80% |
| 2025-04-24 | BML Investment Partners, L.P. | 4.22M | 9.50% |
| 2025-04-23 | GUY LEVY | 2.26M | 5.10% |
| 2025-04-23 | SOLEUS CAPITAL MANAGEMENT, L.P. | 2.26M | 5.10% |
| 2025-04-23 | SOLEUS CAPITAL GROUP, LLC | 2.26M | 5.10% |
| 2025-04-23 | SOLEUS CAPITAL, LLC | 2.26M | 5.10% |
| 2025-04-23 | SOLEUS CAPITAL MASTER FUND, L.P. | 2.26M | 5.10% |
| 2025-04-23 | SOLEUS GP, LLC | 2.26M | 5.10% |
| 2025-04-15 | SOLEUS GP, LLC | 2.26M | 5.10% |
| 2025-04-15 | SOLEUS CAPITAL GROUP, LLC | 2.26M | 5.10% |
| 2025-04-15 | SOLEUS CAPITAL MASTER FUND, L.P. | 2.26M | 5.10% |
| 2025-04-15 | SOLEUS CAPITAL, LLC | 2.26M | 5.10% |
| 2025-04-15 | GUY LEVY | 2.26M | 5.10% |
| 2025-04-15 | SOLEUS CAPITAL MANAGEMENT, L.P. | 2.26M | 5.10% |
| 2025-04-09 | BIOTECHNOLOGY VALUE FUND LP | 4.71M | 10.60% |
| 2025-02-14 | BML Investment Partners, L.P. | 4.22M | 9.50% |
| 2025-02-14 | RTW Investments, LP | 1.11M | 2.50% |
| 2025-02-14 | PFM Health Sciences, LP | - | 0.00% |
| 2025-02-14 | BML Investment Partners, L.P. | 4.18M | 9.40% |
| 2025-02-11 | Soleus Capital Special Opportunities Fund, L.P. | - | 0.00% |
| 2024-11-08 | TANG CAPITAL PARTNERS IV, INC | - | 0.00% |
| 2024-11-08 | TANG CAPITAL MANAGEMENT, LLC | 4.3M | 9.70% |
| 2024-11-08 | KEVIN TANG | 4.3M | 9.70% |
| 2024-11-08 | Concentra Biosciences, LLC | - | 0.00% |
| 2024-11-08 | TANG CAPITAL PARTNERS, LP | 4.3M | 9.70% |
| 2024-11-08 | TANG CAPITAL PARTNERS III, INC | - | 0.00% |
| 2024-02-14 | Roderick Wong, M.D. | 2.3M | 5.20% |
| 2024-02-14 | RTW Investments, LP | 2.3M | 5.20% |
| 2024-02-08 | Morgan Stanley | 4.19M | 9.50% |
| 2024-02-08 | Morgan Stanley & Co. LLC | 4.03M | 9.10% |
| 2022-10-27 | Avidity Partners Management LP | 3.75M | 8.50% |
| 2022-10-27 | Avidity Partners Management (GP) LLC | 3.75M | 8.50% |
| 2022-10-27 | David Witzke | 3.75M | 8.50% |
| 2022-10-27 | Michael Gregory | 3.75M | 8.50% |
| 2022-10-27 | Avidity Master Fund LP | 3.05M | 6.90% |
| 2022-10-27 | Avidity Capital Partners (GP) LLC | 3.75M | 8.50% |
| 2022-10-27 | Avidity Capital Partners Fund (GP) LP | 3.75M | 8.50% |
| 2022-07-12 | Biotechnology Value Fund II, L.P. | 3.49M | 7.90% |
| 2022-07-12 | BVF I GP LLC | 4.71M | 10.70% |
| 2022-07-12 | BVF II GP LLC | 3.49M | 7.90% |
| 2022-07-12 | Biotechnology Value Fund, L.P. | 4.71M | 10.70% |
| 2022-07-12 | Mark N. Lampert | 8.75M | 19.90% |
| 2022-07-12 | BVF Inc. | 8.75M | 19.90% |
| 2022-07-12 | BVF Partners L.P. | 8.75M | 19.90% |
| 2022-07-12 | Biotechnology Value Trading Fund OS LP | 357.47K | 1.00% |
| 2022-07-12 | BVF Partners OS Ltd. | 357.47K | 1.00% |
| 2022-07-12 | BVF GP Holdings LLC | 8.2M | 18.60% |
| 2022-02-14 | RTW Investments, LP | 2.64M | 6.00% |
| 2022-02-14 | Eventide Asset Management, LLC | 3.32M | 7.50% |
| 2022-02-14 | Finny Kuruvilla, M.D. Ph. D. | 3.32M | 7.50% |
| 2022-02-14 | Robin C. John | 3.32M | 7.50% |
| 2022-02-14 | Roderick Wong | 2.64M | 6.00% |
| 2022-02-11 | Pfizer Inc. 13-5315170 | 1.68M | 3.81% |
| 2022-02-11 | Vivo Capital IX, LLC | 119.16K | 0.30% |
| 2022-02-11 | Vivo Opportunity, LLC | 624.9K | 1.40% |
| 2022-02-11 | EIN #00-0000000 | 3.4M | 7.70% |
| 2022-02-10 | Soleus Capital, LLC | 3.53M | 8.01% |
| 2021-08-23 | DRIEHAUS CAPITAL MANAGEMENT LLC | - | 0.00% |
| 2021-07-02 | RTW Investments, LP | 3.03M | 7.49% |
| 2021-07-02 | RTW Master Fund, Ltd. | 2.05M | 5.07% |
| 2021-07-02 | Roderick Wong | 3.03M | 7.49% |
| 2021-05-05 | I.R.S. Identification Nos. of above persons (entities only): N/A | 1.99M | 5.10% |
| 2021-02-16 | DRIEHAUS CAPITAL MANAGEMENT LLC | 1.05M | 5.03% |
| 2021-02-16 | DRIEHAUS CAPITAL MANAGEMENT LLC | 1.05M | 5.03% |
| 2020-11-06 | Vivo Capital IX, LLC | 314.74K | 1.00% |
| 2020-11-06 | Vivo Opportunity, LLC | 1.41M | 4.40% |
| 2020-08-06 | Pfizer Inc. | 1.68M | 6.00% |
| 2019-11-12 | OrbiMed Capital GP VI LLC | 1.47M | 7.10% |
| 2019-11-12 | OrbiMed Advisors LLC | 1.47M | 7.10% |
| 2019-08-30 | Eventide Asset Management, LLC | 2.01M | 9.68% |
| 2019-08-30 | Finny Kuruvilla, M.D. Ph.D. | 2.01M | 9.68% |
| 2019-08-28 | Soleus Capital, LLC | 2.14M | 9.99% |
| 2019-05-23 | Eventide Gilead Fund | 618.97K | 8.60% |
| 2019-05-23 | Eventide Healthcare & Life Sciences Fund | 767K | 10.60% |
| 2019-05-23 | Eventide Asset Management, LLC | 1.39M | 19.20% |
| 2019-05-23 | Finny Kuruvilla, M.D. Ph.D. | 1.39M | 19.20% |
| 2018-02-12 | Eventide Asset Management, LLC | 2.72M | 9.30% |
| 2018-01-16 | Biotechnology Value Fund II, L.P. | 3.14M | 3.10% |
| 2018-01-16 | BVF Partners L.P. | 10M | 9.90% |
| 2018-01-16 | Biotechnology Value Fund, L.P. | 4.73M | 4.70% |
| 2018-01-16 | Mark N. Lampert | 10M | 9.90% |
| 2018-01-16 | BVF Inc. | 10M | 9.90% |
| 2018-01-16 | Biotechnology Value Trading Fund OS LP | 813.61K | 1.00% |
| 2018-01-16 | BVF Partners OS Ltd. | 813.61K | 1.00% |
| 2017-02-13 | Eventide Asset Management, LLC | 2.72M | 9.30% |
| 2017-02-10 | William C. Newton, Gloria A. Newton | 1.69M | 12.46% |
| 2016-01-25 | Richard M. Glickman | 812.5K | 2.90% |
| 2016-01-22 | 9.28% (2) | 2.61M | 9.28% |
| 2016-01-22 | 9.28% (2) | 2.61M | 9.28% |
| 2016-01-22 | 9.28% (2) | 2.61M | 9.28% |
| 2016-01-22 | 9.28% (2) | 2.61M | 9.28% |
| 2016-01-22 | 9.28% (2) | 2.61M | 9.28% |
| 2016-01-22 | 9.28% (2) | 2.61M | 9.28% |
| 2015-07-20 | Deerfield Special Situations Fund, L.P. | 950.19K | 4.20% |
| 2015-07-20 | James E. Flynn | 1.86M | 8.22% |
| 2015-07-20 | Deerfield Mgmt III, L.P. | 909.09K | 4.02% |
| 2015-07-20 | Deerfield Management Company, L.P. | 1.86M | 8.22% |
| 2015-07-20 | Deerfield Mgmt, L.P. | 950.19K | 4.20% |
| 2015-07-20 | Deerfield Private Design Fund III, L.P. | 909.09K | 4.02% |
EPIX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2024-09-30 | $6.06 | 44.28M | $268.32M | $103.71M | $329.26K | $164.94M |
| 2023-09-30 | $3.09 | 44.09M | $136.24M | $33.7M | $80328 | $102.62M |
| 2022-09-30 | $1.82 | 44.04M | $80.15M | $57.08M | $209.83K | $23.28M |
| 2021-09-30 | $8.00 | 38.48M | $307.84M | $137.83M | $330.97K | $170.35M |
| 2020-09-30 | $6.90 | 22.44M | $154.86M | $56.32M | $59094 | $98.6M |
| 2019-09-30 | $3.37 | 8.43M | $28.42M | $53.32M | $3.71M | -$21.19M |
| 2018-09-30 | $3.15 | 4.57M | $14.38M | $14.83M | $3.5M | $3.06M |
| 2017-09-30 | $5.80 | 1.45M | $8.44M | $3.96M | $5.93M | $10.41M |
| 2016-09-30 | $55.00 | 1.35M | $73.99M | $8.98M | -$ | $65M |
| 2015-09-30 | $126.20 | 917.65K | $115.81M | $1.57M | -$ | $114.24M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-06-30 | $1.70 | 44.39M | $75.46M | $85.95M | -$ | -$10.49M |
| 2025-03-31 | $1.58 | 44.39M | $70.13M | $86.31M | $280.2K | -$15.89M |
| 2024-12-31 | $1.79 | 44.37M | $79.42M | $93.31M | $305.04K | -$13.59M |
| 2024-09-30 | $6.06 | 44.37M | $268.86M | $103.71M | $329.26K | $165.48M |
| 2024-06-30 | $5.12 | 44.37M | $227.15M | $85.99M | $342.14K | $141.51M |
| 2024-03-31 | $8.42 | 44.24M | $372.48M | $91.68M | $353.66K | $281.15M |
| 2023-12-31 | $6.60 | 44.13M | $291.25M | $35.34M | $374.84K | $256.28M |
| 2023-09-30 | $3.09 | 44.1M | $136.27M | $33.7M | $80328 | $102.65M |
| 2023-06-30 | $2.70 | 44.09M | $119.05M | $38.47M | $111.27K | $80.69M |
| 2023-03-31 | $2.97 | 44.09M | $130.95M | $44.3M | $20000 | $86.67M |
| 2022-12-31 | $2.52 | 44.07M | $111.06M | $51.22M | $177.96K | $60.02M |
| 2022-09-30 | $1.82 | 44.07M | $80.21M | $57.08M | $209.83K | $23.35M |